GNA Biosolutions

About

GNA Biosolutions is a private molecular diagnostics company.

Munich,Bayern,Germany
11 - 50

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $13.50M
Industries: Biotechnology,Health Care,Health Diagnostics,Medical
Founded date: Jun 22, 2010
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: GNA Biosolutions GmbH

GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$13.50M €6M

GNA Biosolutions has raised a total of $13.50M €6M in funding over 2 rounds. Their latest funding was raised on Aug 6, 2019 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 6, 2019	Series C	$13.50M	9	GreyBird Ventures	—	Detail
Mar 7, 2015	Series B	€6M	6	—	—	Detail
Mar 14, 2011	Series A	—	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

9

GNA Biosolutions is funded by 9 investors. GreyBird Ventures and btov Partners are the most recent investors.

Investor Name	Lead Investor	Funding Round
GreyBird Ventures	Yes	Series C
btov Partners	—	Series C
Robert Bosch Venture Capital	—	Series C
KfW	—	Series C
Mey Capital Matrix	—	Series C
OCCIDENT	—	Series C
SHS Capital	—	Series C
UVC Partners	—	Series C
Wachstumsfonds Bayern	—	Series C